Leveraging these advantages, Zhangjiagang is actively reinforcing and extending its hydrogen energy industrial chain through ...
Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...
Per deal terms, Merck will receive rights outside of the greater China region to the therapy, dubbed HRS-5346 and is ...
The 47th World Skills Competition, held in 2025, is one of the most prestigious technical events on the global stage, featuring skilled professionals from around the world. The remarkable competitors ...
This achievement positions Hefei as the fourth most populated city in the Yangtze River Delta region, following Shanghai, ...
On March 20, the Jiangsu Performing Arts Group announced the lineup of its theater festival week in Beijing, with four stage ...
(MENAFN- GlobeNewsWire - Nasdaq) Global Times: Xi Jinping emphasizes green development, Taihu Lake restoration, and China's eco-friendly modernization efforts. Beijing, China, March 20, 2025 ...
Merck & Co. has agreed to license an investigational oral small molecule lipoprotein (a) inhibitor from Jiangsu Hengrui Pharmaceuticals in a deal potentially worth more than $2 billion to the Chinese ...